AGREEMENT AND PLAN OF MERGER by and among VALEANT PHARMACEUTICALS INTERNATIONAL, ODYSSEUS ACQUISITION CORP., VALEANT PHARMACEUTICALS INTERNATIONAL, INC. and OBAGI MEDICAL PRODUCTS, INC. Dated as of March 19, 2013Agreement and Plan of Merger • March 20th, 2013 • Obagi Medical Products, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2013 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of March 19, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Odysseus Acquisition Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), Obagi Medical Products, Inc., a Delaware corporation (the “Company”), and solely for purposes of Section 6.17 hereof, Valeant Pharmaceuticals International, Inc., a Canadian corporation (“Guarantor”). Certain terms used in this Agreement are used as defined in Section 9.12.